v3.24.2
Condensed Consolidated Statements of Cash Flows (Q1) - USD ($)
 3 Months Ended 12 Months Ended 35 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Cash flows from operating activities                
Net income/(loss) $ (327,599,700) $ (9,177,900) $ (26,033,100) $ (22,768,100) $ (210,300) $ (58,189,200) $ 50,523,700  
Adjustments to reconcile net income / (loss) to net cash used in operating activities:                
Non-cash interest expense on debt 2,817,600       2,024,300 39,429,100 2,038,700  
Change in fair value of derivative liabilities 225,916,000       (5,659,900) 2,791,600 (75,809,900)  
Depreciation 5,600       16,500 60,400 59,100  
Loss on extinguishment of debt 542,300       0      
Stock based compensation 84,588,000       0      
Non-cash charge for operating lease 400       1,800 153,800 86,800  
Prepaid expenses and other current assets 2,800       0 (1,600) 105,200  
Accounts Receivable 33,800       13,200 426,900 (507,800)  
Unearned Revenue (695,900)       0 4,413,100 0  
Accounts payable 5,073,100       39,900 1,332,000 (542,700)  
Net cash used in operating activities (9,316,000)       (3,774,500) (9,733,500) (24,201,500) $ 37,732,000
Cash flows used in investing activities                
Purchases of property and equipment 0       0 (2,200) (84,500)  
Net cash provided by (used in) investing activities 0       0 (2,200) (84,500)  
Cash flows provided by financing activities                
Proceeds from convertible promissory notes 47,455,000       0 3,500,000 15,360,000 40,460,000
Proceeds from merger 233,017,500       0      
Net cash provided by financing activities 280,472,500       0 2,500,000 15,360,000  
Net change in cash 271,156,500       (3,774,500) (7,235,700) (8,926,000)  
Cash and cash equivalents, beginning of period 2,572,700     $ 6,033,900 9,808,400 9,808,400 18,734,400  
Cash and cash equivalents, end of period 273,729,200 2,572,700     6,033,900 2,572,700 9,808,400 2,572,700
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets                
Cash and cash equivalents 233,700,900 2,572,700     6,033,900 2,572,700 9,808,400 2,572,700
Restricted cash 40,028,300 $ 0     0 0   $ 0
Supplemental disclosure of cash flow information                
Cash paid for interest 0       0 0 0  
Cash paid for taxes 0       0 $ 0 $ 0  
Non cash investing and financing activities                
Shares issued for conversion of convertible notes $ 300,426,000       $ 0